DHA but not AA Enhances Cisplatin Cytotoxicity in Ovarian Cancer Cells

References

• Hunn J and Rodriguez GC: Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 55, 3–23, 2012.
   PubMed Web of Science ®Google Scholar
• Goff BA: Advanced ovarian cancer: what should be the standard of care? J Gynecol Oncol 24, 83–91, 2013.
   PubMed Web of Science ®Google Scholar
• Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, et al.: Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One 9, e84941, 2014.
   PubMed Web of Science ®Google Scholar
• Cristea M, Han E, Salmon L, and Morgan RJ: Practical considerations in ovarian cancer chemotherapy. Ther Adv Med Oncol 2, 175–187, 2010.
   PubMedGoogle Scholar
• Morland SL, Martins KJB, and Mazurak VC: N – 3 polyunsaturated fatty acid supplementation during cancer chemotherapy. J Nutr Interm Metab 5, 107–116, 2016.
   Google Scholar
• Schmitz G and Ecker J: The opposing effects of n – 3 and n – 6 fatty acids. Prog Lipid Res 47, 147–155, 2008.
   PubMed Web of Science ®Google Scholar
• Trombetta A, Maggiora M, Martinasso G, Cotogni P, Canuto RA, et al.: Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs. Chem Biol Interact 165, 239–250, 2007.
   PubMed Web of Science ®Google Scholar
• D’Eliseo D and Velotti F: Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy. J Clin Med 5, 2016. doi:10.3390/jcm5020015
   PubMed Web of Science ®Google Scholar
• Merritt MA, Cramer DW, Missmer SA, Vitonis AF, Titus LJ, et al.: Dietary fat intake and risk of epithelial ovarian cancer by tumour histology. Br J Cancer 110, 1392–1401, 2014.
   PubMed Web of Science ®Google Scholar
• Wang D and Dubois RN: Eicosanoids and cancer. Nat Rev Cancer 10, 181–193, 2010.
   PubMed Web of Science ®Google Scholar
• Rocconi RP, Kirby TO, Seitz RS, Beck R, Straughn JM, et al.: Lipoxygenase pathway receptor expression in ovarian cancer. Reprod Sci 15, 321–326, 2008.
   PubMed Web of Science ®Google Scholar
• Seo JM, Park S, and Kim JH: Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2. J Biol Chem 287, 13840–13849, 2012.
   PubMed Web of Science ®Google Scholar
• Kim H, Park GS, Lee JE, and Kim JH: A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells. Br J Cancer 109, 351–359, 2013.
   PubMed Web of Science ®Google Scholar
• Park J, Park SY, and Kim JH: Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade. Biochim Biophys Acta 1863, 236–243, 2016.
   PubMed Web of Science ®Google Scholar
• Abdi J, Garssen J, Faber J, and Redegeld FA: Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells. J Nutr Biochem 25, 1254–1262, 2014.
   PubMed Web of Science ®Google Scholar
• Jeong S, Jing K, Kim N, Shin S, Kim S, et al.: Docosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cells. BMC Cancer 14, 481, 2014.
   PubMed Web of Science ®Google Scholar
• Cao J, Schwichtenberg KA, Hanson NQ, and Tsai MY: Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265–2272, 2006.
   PubMed Web of Science ®Google Scholar
• Sharma A, Belna J, Espat J, Rodriguez G, Cannon VT, et al.: Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer. Am J Obstet Gynecol 200, 511–516, 2009.
   Web of Science ®Google Scholar
• Sharma A, Belna J, Logan J, Espat J, and Hurteau JA: The effects of omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol Oncol 99, 58–64, 2005.
   PubMed Web of Science ®Google Scholar
• Wan XH, Fu X, and Ababaikeli G: Docosahexaenoic acid induces growth suppression on epithelial ovarian cancer cells more effectively than eicosapentaenoic acid. Nutr Cancer 68, 320–327, 2016.
   PubMed Web of Science ®Google Scholar
• Wang YC, Wu YN, Wang SL, Lin QH, He MF, et al.: Docosahexaenoic acid modulates invasion and metastasis of human ovarian cancer via multiple molecular pathways. Int J Gynecol Cancer 26, 994–1003, 2016.
   PubMed Web of Science ®Google Scholar
• Yang YC, Tsao YP, Ho TC, and Choung IP: Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines. Int J Gynecol Cancer 17, 418–425, 2007.
   PubMed Web of Science ®Google Scholar
• Muccioli M and Benencia F: Toll-like receptors in ovarian cancer as targets for immunotherapies. Front Immunol 5, 341, 2014.
   PubMed Web of Science ®Google Scholar
• Jinushi M and Komohara Y: Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside. Biochim Biophys Acta 1855, 123–130, 2015.
   PubMed Web of Science ®Google Scholar
• Subramaniam A, Shanmugam MK, Perumal E, Li F, Nachiyappan A, et al.: Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta 1835, 46–60, 2013.
   PubMed Web of Science ®Google Scholar
• Bishayee K and Khuda-Bukhsh AR: 5-Lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy. Acta Biochim Biophys Sin. (Shanghai) 45, 709–719, 2013.
   PubMed Web of Science ®Google Scholar
• Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, et al.: Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis 10, 73, 2011.
   PubMed Web of Science ®Google Scholar
• Ohmichi M, Hayakawa J, Tasaka K, Kurachi H, and Murata Y: Mechanisms of platinum drug resistance. Trends Pharmacol Sci 26, 113–116, 2005.
   PubMed Web of Science ®Google Scholar
• Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, et al.: Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Natl Cancer Inst 81, 1069–1075, 1989.
   PubMed Web of Science ®Google Scholar
• Barrera G: Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012, 137289, 2012.
   PubMedGoogle Scholar
• Kang KS, Wang P, Yamabe N, Fukui M, Jay T, et al.: Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 5, e10296, 2010.
   PubMed Web of Science ®Google Scholar
• Zajdel A, Wilczok A, and Tarkowski M: Toxic effects of n – 3 polyunsaturated fatty acids in human lung A549 cells. Toxicol In Vitro 30, 486–491, 2015.
   PubMed Web of Science ®Google Scholar
• Cavazos DA, Price RS, Apte SS, and de Graffenried LA: Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. Prostate 71, 1420–1428, 2011.
   PubMed Web of Science ®Google Scholar
• Boldogh I, Roy G, Lee MS, Bacsi A, Hazra TK, et al.: Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress. Toxicology 193, 137–152, 2003.
   PubMed Web of Science ®Google Scholar
• Maiti AK: Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells. Pharmacogenomics J 10, 94–104, 2010.
   PubMed Web of Science ®Google Scholar